© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 11, 824-842,
June 6, 2001
© 2001 Oxford University Press
SPECIAL ARTICLE |
Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing Trends
Affiliations of authors: H. L. Howe, North American Association of Central Cancer Registries, Springfield, IL; P. A. Wingo, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA; M. J. Thun, Epidemiology and Surveillance Research Department, American Cancer Society, Atlanta; L. A. G. Ries, B. K. Edwards (Division of Cancer Control and Population Sciences), E. G. Feigal (Division of Cancer Treatment and Diagnosis), National Cancer Institute, Bethesda, MD; H. M. Rosenberg, Division of Vital Statistics, National Center for Health Statistics, CDC, Hyattsville, MD.
Correspondence to: Holly L. Howe, Ph.D., North American Association of Central Cancer Registries, Inc., 2121 W. White Oaks Dr., Springfield, IL 62704–6495 (e-mail: hhowe{at}naaccr.org).
Background: The American Cancer Society, the National Cancer Institute (NCI), the North American Association of Central Cancer Registries, and the Centers for Disease Control and Prevention, including the National Center for Health Statistics (NCHS), collaborate to provide an annual update on cancer occurrence and trends in the United States. This year's report contains a special feature that focuses on cancers with recent increasing trends. Methods: From 1992 through 1998, age-adjusted rates and annual percent changes are calculated for cancer incidence and underlying cause of death with the use of NCI incidence and NCHS mortality data. Joinpoint analysis, a model of joined line segments, is used to examine long-term trends for the four most common cancers and for those cancers with recent increasing trends in incidence or mortality. Statistically significant findings are based on a P value of .05 by use of a two-sided test. State-specific incidence and death rates for 1994 through 1998 are reported for major cancers. Results: From 1992 through 1998, total cancer death rates declined in males and females, while cancer incidence rates declined only in males. Incidence rates in females increased slightly, largely because of breast cancer increases that occurred in some older age groups, possibly as a result of increased early detection. Female lung cancer mortality, a major cause of death in women, continued to increase but more slowly than in earlier years. In addition, the incidence or mortality rate increased in 10 other sites, accounting for about 13% of total cancer incidence and mortality in the United States. Conclusions: Overall cancer incidence and death rates continued to decline in the United States. Future progress will require sustained improvements in cancer prevention, screening, and treatment.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Pellegriti, F. De Vathaire, C. Scollo, M. Attard, C. Giordano, S. Arena, G. Dardanoni, F. Frasca, P. Malandrino, F. Vermiglio, et al. Papillary Thyroid Cancer Incidence in the Volcanic Area of Sicily J Natl Cancer Inst, November 18, 2009; 101(22): 1575 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tehranifar, A. I. Neugut, J. C. Phelan, B. G. Link, Y. Liao, M. Desai, and M. B. Terry Medical Advances and Racial/Ethnic Disparities in Cancer Survival Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2701 - 2708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Kort, N. Paneth, and G. F. Vande Woude The Decline in U.S. Cancer Mortality in People Born since 1925 Cancer Res., August 15, 2009; 69(16): 6500 - 6505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Markopoulos, A. Polychronis, U. Dafni, D. Koukouras, V. Zobolas, E. Tzorakoleftherakis, G. Xepapadakis, and H. Gogas Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy Ann. Onc., January 1, 2009; 20(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jemal, M. J. Thun, L. A. G. Ries, H. L. Howe, H. K. Weir, M. M. Center, E. Ward, X.-C. Wu, C. Eheman, R. Anderson, et al. Annual Report to the Nation on the Status of Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control J Natl Cancer Inst, December 3, 2008; 100(23): 1672 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nan, T. Niu, D. J. Hunter, and J. Han Missense Polymorphisms in Matrix Metalloproteinase Genes and Skin Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3551 - 3557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Sjo, E. Ralfkiaer, J. U. Prause, J. H. Petersen, J. Madsen, N. T. Pedersen, and S. Heegaard Increasing Incidence of Ophthalmic Lymphoma in Denmark from 1980 to 2005 Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3283 - 3288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Garbe, P. Radny, R. Linse, R. Dummer, R. Gutzmer, J. Ulrich, R. Stadler, M. Weichenthal, TK. Eigentler, U. Ellwanger, et al. Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis Ann. Onc., June 1, 2008; 19(6): 1195 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Dong, D. A. Berry, T. B. Bevers, S.-W. Kau, L. Hsu, R. L. Theriault, and Y. Shen Prognostic Role of Detection Method and Its Relationship with Tumor Biomarkers in Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1096 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Frasca, C Nucera, G Pellegriti, P Gangemi, M Attard, M Stella, M Loda, V Vella, C Giordano, F Trimarchi, et al. BRAF(V600E) mutation and the biology of papillary thyroid cancer Endocr. Relat. Cancer, March 1, 2008; 15(1): 191 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Si, J. Behar, J. Wands, D. G. Beer, D. Lambeth, Y. Eugene Chin, and W. Cao STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G174 - G183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Lange and C. M. Balch Melanoma in Older Patients ASCO Educational Book, January 1, 2008; 2008(1): 399 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Vogel, D. P. Atchley, J. Erlichman, K. R. Broglio, K. J. Ready, V. Valero, C. I. Amos, G. N. Hortobagyi, K. H. Lu, and B. Arun BRCA1 and BRCA2 Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model J. Clin. Oncol., October 10, 2007; 25(29): 4635 - 4641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhou, J. Wulfkuhle, H. Zhang, P. Gu, Y. Yang, J. Deng, J. B. Margolick, L. A. Liotta, E. Petricoin III, and Y. Zhang Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance PNAS, October 9, 2007; 104(41): 16158 - 16163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, D. L. Dai, M. Martinka, and G. Li Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous Melanoma Clin. Cancer Res., July 15, 2007; 13(14): 4111 - 4116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Loser, J. Apelt, M. Voskort, M. Mohaupt, S. Balkow, T. Schwarz, S. Grabbe, and S. Beissert IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice J. Immunol., July 1, 2007; 179(1): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Thieblemont and B. Coiffier Lymphoma in Older Patients J. Clin. Oncol., May 10, 2007; 25(14): 1916 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Quann, F. Khwaja, K. H. Zavitz, and D. Djakiew The Aryl Propionic Acid R-Flurbiprofen Selectively Induces p75NTR-Dependent Decreased Survival of Prostate Tumor Cells Cancer Res., April 1, 2007; 67(7): 3254 - 3262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U.S. Preventive Services Task Force* Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med, March 6, 2007; 146(5): 361 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lonn, P. Bhatti, B. H. Alexander, M. A. Pineda, M. M. Doody, J. P. Struewing, and A. J. Sigurdson Papillary Thyroid Cancer and Polymorphic Variants in TSHR- and RET-Related Genes: a Nested Case-Control Study within a Cohort of U.S. Radiologic Technologists Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 174 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Han, G. A Colditz, and D. J Hunter Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study Int. J. Epidemiol., December 1, 2006; 35(6): 1514 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Ganz Monitoring the Physical Health of Cancer Survivors: A Survivorship-Focused Medical History J. Clin. Oncol., November 10, 2006; 24(32): 5105 - 5111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Cokkinides, M. Weinstock, K. Glanz, J. Albano, E. Ward, and M. Thun Trends in Sunburns, Sun Protection Practices, and Attitudes Toward Sun Exposure Protection and Tanning Among US Adolescents, 1998-2004 Pediatrics, September 1, 2006; 118(3): 853 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Svatek, J. J. Lee, C. G. Roehrborn, S. M. Lippman, and Y. Lotan The cost of prostate cancer chemoprevention: a decision analysis model. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1485 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Fu, D. G. Beer, J. Behar, J. Wands, D. Lambeth, and W. Cao cAMP-response Element-binding Protein Mediates Acid-induced NADPH Oxidase NOX5-S Expression in Barrett Esophageal Adenocarcinoma Cells J. Biol. Chem., July 21, 2006; 281(29): 20368 - 20382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. C. Lau, E. Raja, M. Salto-Tellez, Q. Liu, K. Ito, M. Inoue, T. C. Putti, M. Loh, T. K. Ko, C. Huang, et al. RUNX3 Is Frequently Inactivated by Dual Mechanisms of Protein Mislocalization and Promoter Hypermethylation in Breast Cancer. Cancer Res., July 1, 2006; 66(13): 6512 - 6520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Brandling-Bennett, L. A. Capaldi, B. A. Gilchrest, and A. C. Geller Improving skin cancer prevention and detection education in US medical schools. Arch Dermatol, April 1, 2006; 142(4): 524 - 526. [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Cho, E. J. Kim, S. S. Lim, M. K. Kim, M.-K. Sung, J.-S. Kim, and J. H. Y. Park Trans-10,cis-12, Not cis-9,trans-11, Conjugated Linoleic Acid Inhibits G1-S Progression in HT-29 Human Colon Cancer Cells J. Nutr., April 1, 2006; 136(4): 893 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al. Epidemiology and costs of chronic obstructive pulmonary disease Eur. Respir. J., January 1, 2006; 27(1): 188 - 207. [Full Text] [PDF]
|
|
|
|
 |
|
 T Mitterlechner, M Fiegl, H Muhlbock, W Oberaigner, S Dirnhofer, and A Tzankov Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000 J. Clin. Pathol., January 1, 2006; 59(1): 48 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Morton, S. S. Wang, S. S. Devesa, P. Hartge, D. D. Weisenburger, and M. S. Linet Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood, January 1, 2006; 107(1): 265 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rosenberg, L. A. Wise, J. R. Palmer, N. J. Horton, and L. L. Adams-Campbell A Multilevel Study of Socioeconomic Predictors of Regular Mammography Use Among African-American Women Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2628 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Jung, H. S. Park, I. J. Lee, H. Namkoong, S. M. Shin, G. W. Cho, S.-A. Ha, Y. G. Park, Y. S. Lee, J. Ko, et al. The HCCR Oncoprotein as a Biomarker for Human Breast Cancer Clin. Cancer Res., November 1, 2005; 11(21): 7700 - 7708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Edwards, M. L. Brown, P. A. Wingo, H. L. Howe, E. Ward, L. A. G. Ries, D. Schrag, P. M. Jamison, A. Jemal, X. C. Wu, et al. Annual Report to the Nation on the Status of Cancer, 1975-2002, Featuring Population-Based Trends in Cancer Treatment J Natl Cancer Inst, October 5, 2005; 97(19): 1407 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, C. Eng, and B. Chen Familial Risks for Nonmedullary Thyroid Cancer J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5747 - 5753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bosetti, F. Levi, F. Lucchini, E. Negri, and C. L. Vecchia Lung cancer mortality in European women: recent trends and perspectives Ann. Onc., October 1, 2005; 16(10): 1597 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Cormier, Y. Xing, M. Ding, J. E. Lee, P. F. Mansfield, J. E. Gershenwald, M. I. Ross, and X. L. Du Population-Based Assessment of Surgical Treatment Trends for Patients With Melanoma in the Era of Sentinel Lymph Node Biopsy J. Clin. Oncol., September 1, 2005; 23(25): 6054 - 6062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kedikoglou, K. Syrigos, Y. Skalkidis, F. Ploiarchopoulou, N. Dessypris, and E. Petridou Implementing clinical protocols in oncology: quality gaps and the learning curve phenomenon Eur J Public Health, August 1, 2005; 15(4): 368 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Ansell and J. Armitage Non-Hodgkin Lymphoma: Diagnosis and Treatment Mayo Clin. Proc., August 1, 2005; 80(8): 1087 - 1097. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Delgado, L. M. Martinez, T. T. Sanchez, A. Ramirez, C. Iturria, and G. Gonzalez-Avila Lung Cancer Pathogenesis Associated With Wood Smoke Exposure Chest, July 1, 2005; 128(1): 124 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cho, B. A. Rosner, and G. A. Colditz Risk Factors for Melanoma by Body Site Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1241 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Loser, A. Scherer, M. B. W. Krummen, G. Varga, T. Higuchi, T. Schwarz, A. H. Sharpe, S. Grabbe, J. A. Bluestone, and S. Beissert An Important Role of CD80/CD86-CTLA-4 Signaling during Photocarcinogenesis in Mice J. Immunol., May 1, 2005; 174(9): 5298 - 5305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cho, B. A. Rosner, D. Feskanich, and G. A. Colditz Risk Factors and Individual Probabilities of Melanoma for Whites J. Clin. Oncol., April 20, 2005; 23(12): 2669 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Aguero, M. M. Facchinetti, Z. Sheleg, and A. M. Senderowicz Phenoxodiol, a Novel Isoflavone, Induces G1 Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21WAF1/CIP1 Cancer Res., April 15, 2005; 65(8): 3364 - 3373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Schaefer, K. Wada, H. Takahashi, N. Matsuhashi, S. Ohnishi, M. M. Wolfe, J. R. Turner, A. Nakajima, S. C. Borkan, and L. J. Saubermann Peroxisome Proliferator-Activated Receptor {gamma} Inhibition Prevents Adhesion to the Extracellular Matrix and Induces Anoikis in Hepatocellular Carcinoma Cells Cancer Res., March 15, 2005; 65(6): 2251 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. I. M. Mahler, J. A. Kulik, J. Harrell, A. Correa, F. X. Gibbons, and M. Gerrard Effects of UV Photographs, Photoaging Information, and Use of Sunless Tanning Lotion on Sun Protection Behaviors Arch Dermatol, March 1, 2005; 141(3): 373 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bosetti, M. Malvezzi, L. Chatenoud, E. Negri, F. Levi, and C. La Vecchia Trends in cancer mortality in the Americas, 1970-2000 Ann. Onc., March 1, 2005; 16(3): 489 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. V. Sahani, S. P. Kalva, L. M. Hamberg, P. F. Hahn, C. G. Willett, S. Saini, P. R. Mueller, and T.-Y. Lee Assessing Tumor Perfusion and Treatment Response in Rectal Cancer with Multisection CT: Initial Observations Radiology, March 1, 2005; 234(3): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zupi, M. Scarsella, S. C. Semple, M. Mottolese, P. G. Natali, and C. Leonetti Antitumor Efficacy of bcl-2 and c-myc Antisense Oligonucleotides in Combination with Cisplatin in Human Melanoma Xenografts: Relevance of the Administration Sequence Clin. Cancer Res., March 1, 2005; 11(5): 1990 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Wong, K. Y-Y. Chan, P. F. Macgregor, P. B-S. Lai, J. A. Squire, B. Beheshti, M. Albert, and T. W-T. Leung Transcriptional Profiling Identifies Gene Expression Changes Associated with IFN-{alpha} Tolerance in Hepatitis C-Related Hepatocellular Carcinoma Cells Clin. Cancer Res., February 1, 2005; 11(3): 1319 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Kamath, A. D. Thor, C. Wang, S. M. Edgerton, A. Slusarczyk, D.J. Leary, J. Wang, E.L. Wiley, B. Jovanovic, Q. Wu, et al. Perinucleolar Compartment Prevalence Has an Independent Prognostic Value for Breast Cancer Cancer Res., January 1, 2005; 65(1): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Zapka, S. C. Lemon, E. Puleo, B. Estabrook, R. Luckmann, and S. Erban Patient Education for Colon Cancer Screening: A Randomized Trial of a Video Mailed before a Physical Examination Ann Intern Med, November 2, 2004; 141(9): 683 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Geller, D. L. O'Riordan, S. A. Oliveria, S. Valvo, M. Teich, and A. C. Halpern Overcoming Obstacles to Skin Cancer Examinations and Prevention Counseling for High-Risk Patients: Results of a National Survey of Primary Care Physicians J Am Board Fam Med, November 1, 2004; 17(6): 416 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lazovich, J. Forster, G. Sorensen, K. Emmons, J. Stryker, M.-F. Demierre, A. Hickle, and N. Remba Characteristics Associated With Use or Intention to Use Indoor Tanning Among Adolescents Arch Pediatr Adolesc Med, September 1, 2004; 158(9): 918 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Destounis, P. DiNitto, W. Logan-Young, E. Bonaccio, M. L. Zuley, and K. M. Willison Can Computer-aided Detection with Double Reading of Screening Mammograms Help Decrease the False-Negative Rate? Initial Experience Radiology, August 1, 2004; 232(2): 578 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gohagan, P. Marcus, R. Fagerstrom, P. Pinsky, B. Kramer, and P. Prorok Baseline Findings of a Randomized Feasibility Trial of Lung Cancer Screening With Spiral CT Scan vs Chest Radiograph: The Lung Screening Study of the National Cancer Institute Chest, July 1, 2004; 126(1): 114 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Simon, W. Du, L. Flaherty, P. A. Philip, P. Lorusso, C. Miree, D. Smith, and D. R Brown Factors Associated With Breast Cancer Clinical Trials Participation and Enrollment at a Large Academic Medical Center J. Clin. Oncol., June 1, 2004; 22(11): 2046 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Lev, A. Onn, V. O. Melinkova, C. Miller, V. Stone, M. Ruiz, E. C. McGary, H. N. Ananthaswamy, J. E. Price, and M. Bar-Eli Exposure of Melanoma Cells to Dacarbazine Results in Enhanced Tumor Growth and Metastasis In Vivo J. Clin. Oncol., June 1, 2004; 22(11): 2092 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Aitken, P. H. Youl, M. Janda, M. Elwood, I. T. Ring, J. B. Lowe, and D. W. Firman Validity of Self-reported Skin Screening Histories Am. J. Epidemiol., June 1, 2004; 159(11): 1098 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Sekeres, B. Peterson, R. K. Dodge, R. J. Mayer, J. O. Moore, E. J. Lee, J. Kolitz, M. R. Baer, C. A. Schiffer, A. J. Carroll, et al. Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia Blood, June 1, 2004; 103(11): 4036 - 4042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Facchinetti, A. De Siervi, D. Toskos, and A. M. Senderowicz UCN-01-Induced Cell Cycle Arrest Requires the Transcriptional Induction of p21waf1/cip1 by Activation of Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Cancer Res., May 15, 2004; 64(10): 3629 - 3637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Braga, R. C. Semelka, R. Pietrobon, D. Martin, N. de Barros, and U. Guller Does Hypervascularity of Liver Metastases as Detected on MRI Predict Disease Progression in Breast Cancer Patients? Am. J. Roentgenol., May 1, 2004; 182(5): 1207 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Coppe, Y. Itahana, D. H. Moore, J. L. Bennington, and P.-Y. Desprez Id-1 and Id-2 Proteins as Molecular Markers for Human Prostate Cancer Progression Clin. Cancer Res., March 15, 2004; 10(6): 2044 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Morris, K. G. Billingsley, N. N. Baxter, and L.-M. Baldwin Racial Disparities in Rectal Cancer Treatment: A Population-Based Analysis Arch Surg, February 1, 2004; 139(2): 151 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Stuart, W. Wachsman, C. C. Berry, J. Wang-Rodriguez, L. Wasserman, I. Klacansky, D. Masys, K. Arden, S. Goodison, M. McClelland, et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer PNAS, January 13, 2004; 101(2): 615 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Lee, H. J. Lee, Y.-J. Surh, and C. Y. Lee Vitamin C and cancer chemoprevention: reappraisal Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1074 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Herendeen and C. Lindley Use of NSAIDs for the Chemoprevention of Colorectal Cancer Ann. Pharmacother., November 1, 2003; 37(11): 1664 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Collisson, C. Kleer, M. Wu, A. De, S. S. Gambhir, S. D. Merajver, and M. S. Kolodney Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells Mol. Cancer Ther., October 1, 2003; 2(10): 941 - 948. [Abstract] [Full Text]
|
|
|
|
|
|
K. Monson, D. A. Litvak, and R. J. Bold Surgery in the Aged Population: Surgical Oncology Arch Surg, October 1, 2003; 138(10): 1061 - 1067. [Full Text] [PDF]
|
|
|
|
|
|
C. K. Chang, I. A. Jacobs, V. M. Vizgirda, and G. I. Salti Melanoma in the Elderly Patient Arch Surg, October 1, 2003; 138(10): 1135 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Collisson, A. De, H. Suzuki, S. S. Gambhir, and M. S. Kolodney Treatment of Metastatic Melanoma with an Orally Available Inhibitor of the Ras-Raf-MAPK Cascade Cancer Res., September 15, 2003; 63(18): 5669 - 5673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Weir, M. J. Thun, B. F. Hankey, L. A. G. Ries, H. L. Howe, P. A. Wingo, A. Jemal, E. Ward, R. N. Anderson, and B. K. Edwards Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control J Natl Cancer Inst, September 3, 2003; 95(17): 1276 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Paz-Elizur, M. Krupsky, S. Blumenstein, D. Elinger, E. Schechtman, and Z. Livneh DNA Repair Activity for Oxidative Damage and Risk of Lung Cancer J Natl Cancer Inst, September 3, 2003; 95(17): 1312 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Lev, M. Ruiz, L. Mills, E. C. McGary, J. E. Price, and M. Bar-Eli Dacarbazine Causes Transcriptional Up-Regulation of Interleukin 8 and Vascular Endothelial Growth Factor in Melanoma Cells: A Possible Escape Mechanism from Chemotherapy Mol. Cancer Ther., August 1, 2003; 2(8): 753 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gorden, I. Osman, W. Gai, D. He, W. Huang, A. Davidson, A. N. Houghton, K. Busam, and D. Polsky Analysis of BRAF and N-RAS Mutations in Metastatic Melanoma Tissues Cancer Res., July 15, 2003; 63(14): 3955 - 3957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Sarkar, K. M. W. Rahman, and Y. Li Bax Translocation to Mitochondria Is an Important Event in Inducing Apoptotic Cell Death by Indole-3-Carbinol (I3C) Treatment of Breast Cancer Cells J. Nutr., July 1, 2003; 133(7): 2434S - 2439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Linet, S. Wacholder, and S. H. Zahm Interpreting Epidemiologic Research: Lessons From Studies of Childhood Cancer Pediatrics, July 1, 2003; 112(1): 218 - 232. [Full Text] [PDF]
|
|
|
|
|
|
W. Sienel, S. Dango, U. Woelfle, A. Morresi-Hauf, C. Wagener, J. Brummer, W. Mutschler, B. Passlick, and K. Pantel Elevated Expression of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 Promotes Progression of Non-Small Cell Lung Cancer Clin. Cancer Res., June 1, 2003; 9(6): 2260 - 2266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Wahner-Roedler, D. F. Nelson, I. T. Croghan, S. J. Achenbach, C. S. Crowson, L. C. Hartmann, and W. M. O'Fallon Risk of Breast Cancer and Breast Cancer Characteristics in Women Treated With Supradiaphragmatic Radiation for Hodgkin Lymphoma: Mayo Clinic Experience Mayo Clin. Proc., June 1, 2003; 78(6): 708 - 715. [Abstract] [PDF]
|
|
|
|
|
|
P. Albers, R. Siener, S. Kliesch, L. Weissbach, S. Krege, C. Sparwasser, H. Schulze, A. Heidenreich, W. de Riese, V. Loy, et al. Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial J. Clin. Oncol., April 15, 2003; 21(8): 1505 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Geller, L. Rutsch, K. Kenausis, and Z. Zhang Evaluation of the SunWise School Program The Journal of School Nursing, April 1, 2003; 19(2): 93 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-F. Demierre Time for the National Legislation of Indoor Tanning to Protect Minors Arch Dermatol, April 1, 2003; 139(4): 520 - 524. [Full Text] [PDF]
|
|
|
|
|
|
H. K. Koh and D. K. Walker The Role of State Health Agencies in Cancer Prevention and Control: Lessons Learned from Massachusetts Cancer Epidemiol. Biomarkers Prev., March 1, 2003; 12(3): 261s - 268s. [Full Text] [PDF]
|
|
|
|
|
|
F. Levi, F. Lucchini, E. Negri, P. Boyle, and C. La Vecchia Mortality from major cancer sites in the European Union, 1955-1998 Ann. Onc., March 1, 2003; 14(3): 490 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Butler, R. Sinha, R. C. Millikan, C. F. Martin, B. Newman, M. D. Gammon, A. S. Ammerman, and R. S. Sandler Heterocyclic Amines, Meat Intake, and Association with Colon Cancer in a Population-based Study Am. J. Epidemiol., March 1, 2003; 157(5): 434 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.W.T. Leung, S. Yu, P.J. Johnson, J. Geschwind, T.J. Vogl, K. Engelmann, G.J. Gores, M. Giovannini, J. O'Grady, M. Heneghan, et al. Phase II Study of the Efficacy and Safety of Cisplatin-Epinephrine Injectable Gel Administered to Patients With Unresectable Hepatocellular Carcinoma J. Clin. Oncol., February 15, 2003; 21(4): 652 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Glanz, R. T. Croyle, V. Y. Chollette, and V. W. Pinn Cancer-Related Health Disparities in Women Am J Public Health, February 1, 2003; 93(2): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Herness and R. K. Naz A Novel Human Prostate-specific Gene-1 (HPG-1): Molecular Cloning, Sequencing, and Its Potential Involvement in Prostate Carcinogenesis Cancer Res., January 15, 2003; 63(2): 329 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Li, J. R. Daling, and K. E. Malone Incidence of Invasive Breast Cancer by Hormone Receptor Status From 1992 to 1998 J. Clin. Oncol., January 1, 2003; 21(1): 28 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-F. Demierre and L. Nathanson Chemoprevention of Melanoma: An Unexplored Strategy J. Clin. Oncol., January 1, 2003; 21(1): 158 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boyle and M. E. Leon Epidemiology of colorectal cancer Br. Med. Bull., December 1, 2002; 64(1): 1 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Chan, S. Y. Lam, K. W. Tsang, B. Lam, J. C. M. Ho, K. H. Fu, W. K. Lam, and Y. L. Kwong Aberrant Promoter Methylation in Chinese Patients with Non-Small Cell Lung Cancer: Patterns in Primary Tumors and Potential Diagnostic Application in Bronchoalevolar Lavage Clin. Cancer Res., December 1, 2002; 8(12): 3741 - 3746. [Abstract] [Full Text] [PDF]
|
|